Gil Atzmon, PhD. and Nir Barzilai, M.D.
The Feinberg Initiative will be directed by Peter Davies, PhD. Dr. Davies has been a leader in Alzheimer’s disease research for more than 30 years. He has published more than 250 research papers, and received numerous awards including the City of NY Liberty Medal, the Renee Pollack Award, Westchester County Alzheimer's Association and the first Metropolitan Life Foundation Prize. He is one of only a handful of investigators in the US who have received two Merit Awards from the National Institutes of Health. He is currently Scientific Director at the Litwin-Zucker Center at the Feinstein Institute for Medical Research, North Shore-LIJ Health System. Recently,
Dr. Davies was awarded the 2015 Potamkin Prize for his research.
Gil Atzmon, PhD, is an assistant professor of endocrinology at the Albert Einstein College of Medicine. As a member of the Institute for Aging Research, he provided the basis for approaching genetics. Nir Barzili, M.D., is the director of the Institute for Aging Research at the Albert Einstein College of Medicine. At the Institute for Aging Research, both Dr. Barzilai and Dr. Atzmon have recently been working on the Longevity Genes Project (click to learn more about their research).
Yun Freudenberg-Hua, M.D.
DNA sequences obtained under the Feinberg Initiative will be available to all qualified investigators worldwide. A consortium of European scientists, led by another senior Alzheimer’s disease investigator, Dr. John Hardy (University College, London, UK) will collaborate in analyzing the results, and will extend the range of samples available.
Dr. Freudenberg-Hua is an attending psychiatrist at the North Shore-LIJ Medical Center. She is also an assistant professor of psychiatry and molecular medicine research at the North Shore-LIJ Medical Center. At the Feinberg Initiative,
Dr. Freudenberg-Hua is the primary person in charge of DNA sequence analysis. She was also the first author of the Feinberg Initiative's first publication.